ZEV COHEN: Open Payments
NPI 1881732758 · NANUET, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$668 in 26 payments from 12 companies in 2025. Trend: 2023 $737 · 2024 $1,169 · 2025 $668
Food & beverage: $654Education: $15
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $206 |
| Braeburn Inc. | 4 | $106 |
| Alkermes, Inc. | 4 | $99 |
| ABBVIE INC. | 2 | $44 |
| Novartis Pharmaceuticals Corporation | 2 | $38 |
| Collegium Pharmaceutical, Inc. | 2 | $35 |
| Amgen Inc. | 2 | $33 |
| PFIZER INC. | 1 | $27 |
| Exact Sciences Corporation | 1 | $25 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
Products named: CAPLYTA, BRIXADI, VIVITROL, VRAYLAR, LEQVIO, Belbuca, OTEZLA, PREVNAR 20.
Industry payments across NY — which companies pay providers there.
